Screener
Rapport Therapeutics, Inc. RAPP Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$56.62M-112% | -$19.86M+17.5% | -$33.76M-69.0% | -$26.93M-53.5% | -$26.73M-47.5% | ||
| $212K-15.9% | $227K-7.0% | $265K+1.9% | $256K+16.9% | $252K+21.2% | ||
| $7.2M+64.1% | $6.96M+72.4% | $5.69M+77.4% | $4.74M+48.8% | $4.39M+86.4% | ||
| -$41.46M-65.4% | -$13.06M+35.5% | -$24.7M-71.0% | -$17.47M-6.4% | -$25.07M-53.3% | ||
| $78K+255% | $86K-70.4% | $169K-25.2% | $134K-4.3% | $22K-97.7% | ||
| $25.6M+13.3% | $37.94M+80.4% | -$174.32M— | -$56.78M-7.0% | $22.6M+121% | ||
| $1.41M+2,340% | $531K+10,520% | $311K+4,343% | $270.53M— | -$63K-100% | ||
| —— | $25.41M+3,080% | -$198.71M— | $196.29M+377% | -$2.54M-107% | ||
| -$41.53M-65.5% | -$13.15M+36.0% | -$24.87M-69.5% | -$17.6M-6.3% | -$25.09M-44.9% |
FAQ
- How much cash does Rapport Therapeutics, Inc. generate?
- Rapport Therapeutics, Inc. (RAPP) generated -$96.7M in operating cash flow over the trailing twelve months.
- What is Rapport Therapeutics, Inc.'s free cash flow?
- After $467.0K of capital expenditures, Rapport Therapeutics, Inc.'s free cash flow was -$97.1M over the trailing twelve months, down 26.4% year over year.
- Where does Rapport Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Rapport Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
